Plasminogen Activator Inhibitor-1 Measurement

Known as: PAI1, Plasminogen Activator Inhibitor-1 
The determination of the amount of plasminogen activator inhibitor-1 present in a sample.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
BACKGROUND & AIMS Biliary atresia (BA) is a progressive fibroinflammatory disorder of infants involving the extrahepatic and… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2013
2013
Idiopathic pulmonary fibrosis (IPF) is a progressive and life threatening disease with median survival of 2.5-3 years. The IPF… (More)
Is this relevant?
2011
2011
PURPOSE The bone morphogenic protein (BMP) antagonist gremlin is elevated in glaucomatous trabecular meshwork (TM) cells and… (More)
Is this relevant?
2010
2010
Various cytokines and inflammatory mediators are known to be involved in the pathogenesis of rheumatoid arthritis (RA). We… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2009
2009
With great interest we read the article Two distinct expression patterns of urokinase, urokinase receptor and plasminogen… (More)
  • figure 1
Is this relevant?
2008
2008
There are strong associations between measures of inflammation and type 2 diabetes, but the causal directions of these… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
2007
Highly Cited
2007
BACKGROUND AND AIM Overexpression of matrix metalloproteinase (MMP)-1, -3, -7, -9, and plasminogen activator inhibitor-1 (PAI-1… (More)
Is this relevant?
2005
2005
Testosterone induces a lethal outcome in otherwise self-healing blood-stage malaria caused by Plasmodium chabaudi. Here, we… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
2002
2002
Highly multiplexed genotyping methods are needed to support a comprehensive analysis of single nucleotide polymorphisms (SNPs) in… (More)
Is this relevant?
1989
1989
The involvement of the erythropoietin (EPO), plasminogen activator inhibitor type I (PAI1), and multi-drug resistance (MDR2… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?